Literature DB >> 30093457

Fibroblast Growth Factor-23 May Follow Cardiovascular Disease Rather than Causing It in Chronic Kidney Disease.

Chenchen Zhou1,2, Changlin Mei2, Bing Dai2, Cheng Xue3.   

Abstract

Entities:  

Keywords:  cardiovascular disease; chronic kidney disease; fibroblast

Mesh：

Substances：

Year:  2018        PMID： 30093457      PMCID： PMC6171268          DOI： 10.1681/ASN.2018050517

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  5 in total

Review 1.  Fibroblast Growth Factor 23 Predicts All-Cause Mortality in a Dose-Response Fashion in Pre-Dialysis Patients with Chronic Kidney Disease.

Authors:  Cheng Xue; Bo Yang; Chenchen Zhou; Bing Dai; Yawei Liu; Zhiguo Mao; Shengqiang Yu; Changlin Mei
Journal:  Am J Nephrol       Date:  2016-12-23       Impact factor: 3.754

2.  Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.

Authors:  Ming Chang Hu; Mingjun Shi; Han Jun Cho; Beverley Adams-Huet; Jean Paek; Kathy Hill; John Shelton; Ansel P Amaral; Christian Faul; Masatomo Taniguchi; Myles Wolf; Markus Brand; Masaya Takahashi; Makoto Kuro-O; Joseph A Hill; Orson W Moe
Journal:  J Am Soc Nephrol       Date:  2014-10-17       Impact factor: 10.121

3.  Cardiac hypertrophy elevates serum levels of fibroblast growth factor 23.

Authors:  Isao Matsui; Tatsufumi Oka; Yasuo Kusunoki; Daisuke Mori; Nobuhiro Hashimoto; Ayumi Matsumoto; Karin Shimada; Satoshi Yamaguchi; Keiichi Kubota; Sayoko Yonemoto; Tomoaki Higo; Yusuke Sakaguchi; Yoshitsugu Takabatake; Takayuki Hamano; Yoshitaka Isaka
Journal:  Kidney Int       Date:  2018-05-08       Impact factor: 10.612

Review 4.  Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis.

Authors:  Amarnath Marthi; Killian Donovan; Richard Haynes; David C Wheeler; Colin Baigent; Christopher M Rooney; Martin J Landray; Sharon M Moe; Jun Yang; Lisa Holland; Romina di Giuseppe; Annet Bouma-de Krijger; Borislava Mihaylova; William G Herrington
Journal:  J Am Soc Nephrol       Date:  2018-05-15       Impact factor: 10.121

5.  Genetic Ablation of Fgf23 or Klotho Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload.

Authors:  Svetlana Slavic; Kristopher Ford; Magalie Modert; Amarela Becirovic; Stephan Handschuh; Andreas Baierl; Nejla Katica; Ute Zeitz; Reinhold G Erben; Olena Andrukhova
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379
  5 in total
  2 in total

1.  Authors' Reply.

Authors:  William G Herrington; Killian Donovan; Borislava Mihaylova
Journal:  J Am Soc Nephrol       Date:  2018-07-13       Impact factor: 10.121

Review 2.  FGF23, Biomarker or Target?

Authors:  Cristian Rodelo-Haad; Rafael Santamaria; Juan R Muñoz-Castañeda; M Victoria Pendón-Ruiz de Mier; Alejandro Martin-Malo; Mariano Rodriguez
Journal:  Toxins (Basel)       Date:  2019-03-22       Impact factor: 4.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.